ArticleJournal of asthma and allergy2021

Real-World Multicenter Experience with Mepolizumab and Benralizumab in the Treatment of Uncontrolled Severe Eosinophilic Asthma Over 12 Months.

Moritz Z Kayser et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.